drugset / Trial / NCT03342859
Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned
Non-randomizedParallel-groupOpen-labelOther
Summary
To investigate the clinical effects of vilaprisan and ulipristal acetate at molecular and cellular level on uterine and fibroid tissue taken from patients (after surgery / biopsy)
Timeline
- Start
- 2017-11-16
- Primary completion
- 2018-12-17
- Completion
- 2020-01-13
Outcome
Outcome not reported
Stopped: “Due to findings in the preclinical carcinogenicity studies for vilaprisan (BAY1002670)”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ulipristal Acetate | Unknown | 5 mg | Oral |
| Subject | Vilaprisan | Other / unclassified | 2 mg | Oral |